Rafael Rosell

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 35

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

British journal of cancer

Lung Cancer (Auckland, N.Z.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, Thanyanan Reungwetwattana, Myung-Ju Ahn, Darren W T Lim, Edgardo S Santos, Elaine Shum, Sally C M Lau, Jii Bum Lee, Antonio Calles, Fengying Wu, Gilberto Lopes, Virote Sriuranpong, Junko Tanizaki, Hidehito Horinouchi, Marina C Garassino, Sanjay Popat, Benjamin Besse, Rafael Rosell, Ross A Soo
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey. Lung Cancer (Auckland, N.Z.) 15 (2024)
Rita Manguinhas, Patrícia A Serra, Rita B Soares, Rafael Rosell, Nuno Gil, Nuno G Oliveira, Rita C Guedes
Unveiling Novel ERCC1-XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental Design. International journal of molecular sciences 25 (2) (2024)
Juan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado, Maria Gonzales Cao, Samuel Gonçalves-Ribeiro, Sara Ruiz Gil, Dmytro Pravdyvets, Samandhy Cedeño, Maurizio Callari, Antonio Marra, Andrea M Gazzo, Jorge S Reis-Filho, Fresia Pareja, Theodore Vougiouklakis, Achim A Jungbluth, Rafael Rosell, Christian Brander, Francesc Tresserra, Jorge Sergio Reis-Filho, Daniel Guimarães Tiezzi, Nuria de la Iglesia, Holger Heyn, Leticia De Mattos-Arruda
Converging and evolving immuno-genomic routes toward immune escape in breast cancer. Nature communications 15 (1) (2024)
Juan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado, Maria Gonzales Cao, Samuel Gonçalves-Ribeiro, Sara Ruiz Gil, Dmytro Pravdyvets, Samandhy Cedeño, Maurizio Callari, Antonio Marra, Andrea M Gazzo, Jorge S Reis-Filho, Fresia Pareja, Theodore Vougiouklakis, Achim A Jungbluth, Rafael Rosell, Christian Brander, Francesc Tresserra, Jorge Sergio Reis-Filho, Daniel Guimarães Tiezzi, Nuria de la Iglesia, Holger Heyn, Leticia De Mattos-Arruda
Converging and evolving immuno-genomic routes toward immune escape in breast cancer. Nature communications 15 (1) (2024)
Maria González-Cao, Xueting Cai, Jillian Wilhelmina Paulina Bracht, Xuan Han, Yang Yang, Carlos Pedraz-Valdunciel, Teresa Morán, Javier García-Corbacho, Andrés Aguilar, Reyes Bernabé, Pedro De Marchi, Luciane Sussuchi da Silva, Leticia Ferro Leal, Rui Manuel Vieira Reis, Jordi Codony-Servat, Eloísa Jantus-Lewintre, Miguel Angel Molina-Vila, Peng Cao, Rafael Rosell
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer. Lung Cancer (Auckland, N.Z.) 15 (2024)
Juan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado, Maria Gonzales Cao, Samuel Gonçalves-Ribeiro, Sara Ruiz Gil, Dmytro Pravdyvets, Samandhy Cedeño, Maurizio Callari, Antonio Marra, Andrea M Gazzo, Jorge S Reis-Filho, Fresia Pareja, Theodore Vougiouklakis, Achim A Jungbluth, Rafael Rosell, Christian Brander, Francesc Tresserra, Jorge Sergio Reis-Filho, Daniel Guimarães Tiezzi, Nuria de la Iglesia, Holger Heyn, Leticia De Mattos-Arruda
Converging and evolving immuno-genomic routes toward immune escape in breast cancer. Nature communications 15 (1) (2024)
Rita Manguinhas, Patrícia A Serra, Rita B Soares, Rafael Rosell, Nuno Gil, Nuno G Oliveira, Rita C Guedes
Unveiling Novel ERCC1-XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental Design. International journal of molecular sciences 25 (2) (2024)
Sai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, Thanyanan Reungwetwattana, Myung-Ju Ahn, Darren W T Lim, Edgardo S Santos, Elaine Shum, Sally C M Lau, Jii Bum Lee, Antonio Calles, Fengying Wu, Gilberto Lopes, Virote Sriuranpong, Junko Tanizaki, Hidehito Horinouchi, Marina C Garassino, Sanjay Popat, Benjamin Besse, Rafael Rosell, Ross A Soo
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey. Lung Cancer (Auckland, N.Z.) 15 (2024)
Rafael Rosell
RE: Reply to Rio-Vilariño and colleagues' article and misconception about YAP1 Ser 397 phosphorylation function. British journal of cancer 130 (12) (2024)
Rafael Rosell
RE: Reply to Rio-Vilariño and colleagues' article and misconception about YAP1 Ser 397 phosphorylation function. British journal of cancer 130 (12) (2024)
Maria González-Cao, Xueting Cai, Jillian Wilhelmina Paulina Bracht, Xuan Han, Yang Yang, Carlos Pedraz-Valdunciel, Teresa Morán, Javier García-Corbacho, Andrés Aguilar, Reyes Bernabé, Pedro De Marchi, Luciane Sussuchi da Silva, Leticia Ferro Leal, Rui Manuel Vieira Reis, Jordi Codony-Servat, Eloísa Jantus-Lewintre, Miguel Angel Molina-Vila, Peng Cao, Rafael Rosell
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer. Lung Cancer (Auckland, N.Z.) 15 (2024)
Rafael Rosell
RE: Reply to Rio-Vilariño and colleagues' article and misconception about YAP1 Ser 397 phosphorylation function. British journal of cancer (2024)
Juan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado, Maria Gonzales Cao, Samuel Gonçalves-Ribeiro, Sara Ruiz Gil, Dmytro Pravdyvets, Samandhy Cedeño, Maurizio Callari, Antonio Marra, Andrea M Gazzo, Jorge S Reis-Filho, Fresia Pareja, Theodore Vougiouklakis, Achim A Jungbluth, Rafael Rosell, Christian Brander, Francesc Tresserra, Jorge Sergio Reis-Filho, Daniel Guimarães Tiezzi, Nuria de la Iglesia, Holger Heyn, Leticia De Mattos-Arruda
Converging and evolving immuno-genomic routes toward immune escape in breast cancer. Nature communications 15 (1) (2024)
Rafael Rosell
RE: Reply to Rio-Vilariño and colleagues' article and misconception about YAP1 Ser 397 phosphorylation function. British journal of cancer 130 (12) (2024)
Rafael Rosell
RE: Reply to Rio-Vilariño and colleagues' article and misconception about YAP1 Ser 397 phosphorylation function. British journal of cancer 130 (12) (2024)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Rafael Rosell, Andrés Aguilar-Hernández, María González-Cao
Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer. Cancers 15 (9) (2023)
Rita B Soares, Rita Manguinhas, João Guilherme Costa, Nuno Saraiva, Nuno Gil, Rafael Rosell, Sérgio Póvoas Camões, Ines Batinic-Haberle, Ivan Spasojevic, Matilde Castro, Joana Paiva Miranda, Paula Guedes de Pinho, Ana Fátima Carvalho Fernandes, Nuno G Oliveira
The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP 5+ , Impairs the Migration and Invasion of Non-Small Cell Lung Cancer Cells, Either Alone or Combined with Cisplatin. Cancers 15 (15) (2023)
Rafael Rosell, María González-Cao
Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab. Nature reviews. Clinical oncology (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Rafael Rosell, Andrés Aguilar-Hernández, María González-Cao
Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer. Cancers 15 (9) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Carlos Pedraz-Valdunciel, Stavros Giannoukakos, Nicolas Potie, Ana Giménez-Capitán, Chung-Ying Huang, Michael Hackenberg, Alberto Fernandez-Hilario, Jill Bracht, Martyna Filipska, Erika Aldeguer, Sonia Rodríguez, Trever G Bivona, Sarah Warren, Cristina Aguado, Masaoki Ito, Andrés Aguilar-Hernández, Miguel Ángel Molina-Vila, Rafael Rosell
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens. Molecular oncology 16 (12) (2022)
Andrés Felipe Cardona, Camila Ordóñez-Reyes, Alejandro Ruíz-Patiño, Juan Esteban Garcia-Robledo, Lucia Zatarain Barron, Gonzalo Recondo, Leonardo Rojas, Luis Corrales-Rodríguez, Claudio Marcelo Martin, Feliciano Barrón, Carolina Sotelo-Rodríguez, July Rodríguez, Luisa Ricaurte, Christian C Rolfo, Jenny Ávila, Diana Mayorga, Pilar Archila, Jorge Otero, Luis Mas, Maritza Bermudez, Tatiana Gamez, Hernán Carranza, Carlos Vargas, Rafael Rosell, Arrieta Oscar
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP). JCO precision oncology 5 (2022)
Rafael Rosell, Andrés Aguilar, Carlos Pedraz, Imane Chaib
KRAS inhibitors, approved. Nature cancer 2 (12) (2022)
Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R Brahmer, Paul Celano, Narjust Florez, Peter M Ellis, Ivy B Elkins, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, David H Johnson, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Tanyanika Phillips, Gregory J Riely, Nicholas G Zaorsky, Rafael Rosell, Joan H Schiller, Bryan J Schneider, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R Brahmer, Paul Celano, Narjust Florez, Peter M Ellis, Ivy B Elkins, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, David H Johnson, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Tanyanika Phillips, Gregory J Riely, Nicholas G Zaorsky, Rafael Rosell, Joan H Schiller, Bryan J Schneider, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Martyna Filipska, Rafael Rosell
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment. Molecular oncology 15 (6) (2021)
Rafael Rosell, Andrés Felipe Cardona, Oscar Arrieta, Andrés Aguilar, Masaoki Ito, Carlos Pedraz, Jordi Codony-Servat, Mariacarmela Santarpia
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities. British journal of cancer 125 (12) (2021)
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H Johnson, Natasha B Leighl, Pamela R Moffitt, Tanyanika Phillips, Gregory J Riely, Rafael Rosell, Joan H Schiller, Bryan J Schneider, Navneet Singh, David R Spigel, Joan Tashbar, Gregory A Masters
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Alexander E Drilon, Michael Duruisseaux, Ji-Youn Han, Masaoki Ito, Christina J Falcon, Soo-Ryum Yang, Yonina R Murciano-Goroff, Haiquan Chen, Morihito Okada, Miguel Ángel Molina-Vila, Marie Wislez, Philippe Brun, Clarisse Dupont, Eva Branden, Giulio Rossi, Alexa B Schrock, Siraj M Ali, Valérie Gounant, Fanny Magne, Torsten Gerriet Blum, Alison M Schram, Isabelle Monnet, Jin-Yuan Shih, Joshua K Sabari, Maurice Pérol, Viola W Zhu, Misako Nagasaka, Robert Doebele, D Ross Camidge, Maria Arcila, Sai-Hong Ignatius Ou, Denis Moro-Sibilot, Rafael Rosell, Lucia Anna Muscarella, Stephen V Liu, Jacques Cadranel
Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)
Guofeng Yue, Xia Sun, Ana Gimenez-Capitan, Jie Shen, Lixia Yu, Cristina Teixido, Wenxian Guan, Rafael Rosell, Baorui Liu, Jia Wei
TAZ is highly expressed in gastric signet ring cell carcinoma. BioMed research international 2014 (2014)